Actuación del Hospital General de la Defensa en Zaragoza durante la pandemia ocasionada por el nuevo coronavirus SARS-CoV-19

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

RESUMEN La pandemia provocada por el virus SARS-CoV-2 ha supuesto una verdadera tragedia sanitaria a nivel mundial, generando graves consecuencias de morbimortalidad, especialmente en personas mayores. El Hospital General de la Defensa (HGDZ) ha participado en la Operación Balmis de las Fuerzas Armadas (FAS) para combatir esta pandemia. Esto ha exigido al HGDZ una gran flexibilidad y capacidad de adaptación para afrontar la gran demanda de ingreso de pacientes infectados por este virus. Para ello, ha Implantado un conjunto creciente de medidas centradas en reforzar la respuesta en el ámbito de la salud y reducir las tasas de contagio.

Translated abstract

SUMMARY The pandemic caused by the SARS-CoV-2 virus has been a true health tragedy worldwide, generating serious consequences of morbidity and mortality, especially in older people. The General Defense Hospital (HGDZ) has participated in Operation Balmis of the Armed Forces (FAS) to fight against this pandemic. It has required HGDZ great flexibility and adaptability to face the high demand for admission of patients infected with this virus. To this aim, it has implemented a growing set of measures focused on strengthening the response in the health field and reducing contagion rates.

Related collections

Most cited references 10

Record: found
Abstract: found
Article: not found

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Marina Pollán, Beatriz Pérez-Gómez, Roberto Pastor-Barriuso … (2020)

Summary Background Spain is one of the European countries most affected by the COVID-19 pandemic. Serological surveys are a valuable tool to assess the extent of the epidemic, given the existence of asymptomatic cases and little access to diagnostic tests. This nationwide population-based study aims to estimate the seroprevalence of SARS-CoV-2 infection in Spain at national and regional level. Methods 35 883 households were selected from municipal rolls using two-stage random sampling stratified by province and municipality size, with all residents invited to participate. From April 27 to May 11, 2020, 61 075 participants (75·1% of all contacted individuals within selected households) answered a questionnaire on history of symptoms compatible with COVID-19 and risk factors, received a point-of-care antibody test, and, if agreed, donated a blood sample for additional testing with a chemiluminescent microparticle immunoassay. Prevalences of IgG antibodies were adjusted using sampling weights and post-stratification to allow for differences in non-response rates based on age group, sex, and census-tract income. Using results for both tests, we calculated a seroprevalence range maximising either specificity (positive for both tests) or sensitivity (positive for either test). Findings Seroprevalence was 5·0% (95% CI 4·7–5·4) by the point-of-care test and 4·6% (4·3–5·0) by immunoassay, with a specificity–sensitivity range of 3·7% (3·3–4·0; both tests positive) to 6·2% (5·8–6·6; either test positive), with no differences by sex and lower seroprevalence in children younger than 10 years ( 10%) and lower in coastal areas (<3%). Seroprevalence among 195 participants with positive PCR more than 14 days before the study visit ranged from 87·6% (81·1–92·1; both tests positive) to 91·8% (86·3–95·3; either test positive). In 7273 individuals with anosmia or at least three symptoms, seroprevalence ranged from 15·3% (13·8–16·8) to 19·3% (17·7–21·0). Around a third of seropositive participants were asymptomatic, ranging from 21·9% (19·1–24·9) to 35·8% (33·1–38·5). Only 19·5% (16·3–23·2) of symptomatic participants who were seropositive by both the point-of-care test and immunoassay reported a previous PCR test. Interpretation The majority of the Spanish population is seronegative to SARS-CoV-2 infection, even in hotspot areas. Most PCR-confirmed cases have detectable antibodies, but a substantial proportion of people with symptoms compatible with COVID-19 did not have a PCR test and at least a third of infections determined by serology were asymptomatic. These results emphasise the need for maintaining public health measures to avoid a new epidemic wave. Funding Spanish Ministry of Health, Institute of Health Carlos III, and Spanish National Health System.

0 comments Cited 932 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: found
Article: not found

Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2 ☆

César Cinesi Gómez, Óscar Peñuelas Rodríguez, Manel Luján Torné … (2020)

Resumen La enfermedad por coronavirus 2019 (COVID-19) es una infección del tracto respiratorio causada por un nuevo coronavirus emergente que se reconoció por primera vez en Wuhan, China, en diciembre de 2019. Actualmente la Organización Mundial de la Salud (OMS) ha definido la infección como pandemia y existe una situación de emergencia sanitaria y social para el manejo de esta nueva infección. Mientras que la mayoría de las personas con COVID-19 desarrollan solo una enfermedad leve o no complicada, aproximadamente el 14% desarrollan una enfermedad grave que requiere hospitalización y oxígeno, y el 5% pueden requerir ingreso en una unidad de cuidados intensivos. En casos severos, COVID-19 puede complicarse por el síndrome de dificultad respiratoria aguda (SDRA), sepsis y shock séptico y fracaso multiorgánico. Este documento de consenso se ha preparado sobre directrices basadas en evidencia desarrolladas por un panel multidisciplinario de profesionales médicos de cuatro sociedades científicas españolas (Sociedad Española de Medicina Intensiva y Unidades Coronarias [SEMICYUC], Sociedad Española de Neumología y Cirugía Torácica [SEPAR], Sociedad Española de Urgencias y Emergencias [SEMES], Sociedad Española de Anestesiología, Reanimación y Terapéutica del Dolor [SEDAR]) con experiencia en el manejo clínico de pacientes con COVID-19 y otras infecciones virales, incluido el SARS, así como en sepsis y SDRA. El documento proporciona recomendaciones clínicas para el soporte respiratorio no invasivo (ventilación no invasiva, oxigenoterapia de alto flujo con cánula nasal) en cualquier paciente con presentación sospechada o confirmada de COVID-19 con insuficiencia respiratoria aguda. Esta guía de consenso debe servir como base para una atención optimizada y garantizar la mejor posibilidad de supervivencia, así como permitir una comparación fiable de las futuras intervenciones terapéuticas de investigación que formen parte de futuros estudios observacionales o de ensayos clínicos.

0 comments Cited 45 times – based on 0 reviews      Review now

Bookmark

Record: found
Abstract: not found
Book: not found

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)

(2020)

0 comments Cited 7 times – based on 0 reviews

Bookmark

All references

Author and article information

Journal

Journal ID (publisher-id): sm

Title: Sanidad Militar

Abbreviated Title: Sanid. Mil.

Publisher: Ministerio de Defensa (Madrid, Madrid, Spain )

ISSN (Print): 1887-8571

Publication date (Print and electronic): September 2020

Volume: 76

Issue: 3

Pages: 183-185

Affiliations

[1] orgnameHospital General de la Defensa en Zaragoza orgdiv1Servicio de Medicina Preventiva

[2] orgnameHospital General de la Defensa en Zaragoza orgdiv1Servicio de Bromatología y Veterinaria

[5] orgnameHospital General de la Defensa en Zaragoza orgdiv1Servicio de Microbiología

[3] orgnameHospital General de la Defensa en Zaragoza orgdiv1Servicio de Prevención de Riesgos Laborales

[4] orgnameHospital General de la Defensa en Zaragoza orgdiv1Servicio de Medicina Hiperbárica

Article

Publisher ID: S1887-85712020000300183 Publisher ID: S1887-8571(20)07600300183

DOI: 10.4321/s1887-85712020000300008

SO-VID: 70a1a08d-a8c1-498e-a3c1-8da0e4975b32

License:

http://creativecommons.org/licenses/by/4.0/

History

Date received : 21 July 2020

Date accepted : 22 September 2020

Page count

Figures: 0, Tables: 0, Equations: 0, References: 10, Pages: 3

Product

SciELO Spain

Comments

Comment on this article

scite_

Most referenced authors 230

See all reference authors

Actuación del Hospital General de la Defensa en Zaragoza durante la pandemia ocasionada por el nuevo coronavirus SARS-CoV-19 Translated title: Performance of the General Defense Hospital in Zaragoza during the pandemic caused by the new SARS-CoV-19 coronavirus

Read this article at

Abstract

Translated abstract

Related collections

Novel Coronavirus Disease COVID-19

Most cited references 10

Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

Recomendaciones de consenso respecto al soporte respiratorio no invasivo en el paciente adulto con insuficiencia respiratoria aguda secundaria a infección por SARS-CoV-2 ☆

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)

Author and article information

Journal

Affiliations

Article

History

Page count

Product

Categories

Comments

Comment on this article

Similar content 199

Most referenced authors 230